Advertisement

The Scientist

» drug development and microbiology

Most Recent

image: Ebola Update

Ebola Update

By | October 23, 2014

Vaccine testing could start soon; Spanish nurse declared free of virus; travelers from West Africa restricted to five US airports

0 Comments

image: Jet Lag Upsets Gut Microbes

Jet Lag Upsets Gut Microbes

By | October 17, 2014

Frequent airplane travel may contribute to obesity by throwing off circadian rhythms and changing the composition of the intestinal microbiome, according to a new study.

0 Comments

image: Nurse Infected with Ebola in Spain

Nurse Infected with Ebola in Spain

By | October 6, 2014

The case marks the first person to contract the virus outside of West Africa.

0 Comments

image: The Ocular Microbiome

The Ocular Microbiome

By | October 1, 2014

Researchers are beginning to study in depth the largely uncharted territory of the eye’s microbial composition.

0 Comments

image: Soil Microbiome of Central Park

Soil Microbiome of Central Park

By | September 30, 2014

Nearly 600 soil samples from New York City’s famous park reveal that the urban environment harbors just as much biodiversity as natural ecosystems across the globe.

1 Comment

image: FDA OKs siRNA Ebola Drug

FDA OKs siRNA Ebola Drug

By | September 23, 2014

The US Food and Drug Administration gives the green light to deploy an experimental short interfering RNA treatment against Ebola.

0 Comments

image: Intensive Loss of Gut Bacteria Diversity

Intensive Loss of Gut Bacteria Diversity

By | September 23, 2014

Lengthy stints in intensive care units pare down patients’ gut microflora, a study shows.

0 Comments

image: Small Molecule Superstore

Small Molecule Superstore

By | September 15, 2014

An analysis of bacterial sequences from the Human Microbiome Project has uncovered thousands of biosynthetic gene clusters.

0 Comments

image: Ebola Vaccine Protects Macaques

Ebola Vaccine Protects Macaques

By | September 9, 2014

Human trials are now underway.

0 Comments

image: FDA Gives Nod to Melanoma Drug

FDA Gives Nod to Melanoma Drug

By | September 8, 2014

The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.

2 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Synthetic Genomics
Synthetic Genomics
Advertisement
Life Technologies